New nanomedicine resolves inflammation, promotes tissue healing
A multicenter team of researchers, including scientists at Columbia University Medical Center (CUMC), Brigham and Women’s Hospital (BWH), Mount Sinai […]
Pharma
World Autism Awareness Day – April 2, 2013
Secretary-General’s Message for 2013 :: “World Autism Awareness Day has succeeded in calling greater international attention to autism and other […]
Opto Circuits’ subsidiary, Cardiac Science, rationalizes its product offering by spinning off its Diagnostic Cardiology product line
Cardiac Science, an Opto Circuits group company, signed a definitive agreement on 29th March 2013 to sell its Diagnostic Cardiology […]
Physicians prefer a shielded EHR view
Even as policymakers are pushing patient engagement, a new survey signals doctors may not be ready to relinquish control of […]
Ranbaxy resumes supply of Atorvastatin tablets in US market
Drug major Ranbaxy Laboratories on Monday said it has resumed the supply of Atorvastatin calcium tablets, a cholesterol lowering drug, […]
Now, drug prices may be capped at time of launch
The government is considering a proposal to cap the prices of all medicines at the time of launch. This could […]
The changing scenario of Healthcare IT in 2013
Every New Year brings the promise of change, but even though it’s still early, when it comes to the world […]
Novartis AG to reduce stake in Novartis India
Novartis India said that its Swiss-pormoter Novartis AG plans to reduce its stake in the Indian entity to enable the […]
WHO cites TB threat
World Health Organization and Global Fund cite tuberculosis threat Urgent need for US$ 1.6 billion a year in international […]
OMRON India launches Auto coding and lightweight Blood Glucose Monitor
OMRON Healthcare India, the leader in innovative medical technologies and products for monitoring and therapy, announced the launch of easy-to-use, […]
Essential drug makers can no longer quit without informing govt
Pharma companies can no longer quit making essential drugs at will, citing non-viability, without informing the government. Drug makers will […]
Drug prices continue to remain out of control
The proposed drug pricing policy is riddled with a host of anomalies. Extending price control to all “essential” medicines will […]
Generic sales boost for Ranbaxy
The much awaited US approval for Ranbaxy Laboratories’ generic version of anti-hypertension drug Diovan is likely to come this week, […]
